CRW vs. EMIS, INS, KOO, RENX, COG, INHC, FDBK, TRLS, IQAI, and DVRG
Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), Trellus Health (TRLS), IQ-AI (IQAI), and DeepVerge (DVRG). These companies are all part of the "health information services" industry.
Craneware vs.
EMIS Group (LON:EMIS) and Craneware (LON:CRW) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations, community ranking and media sentiment.
EMIS Group received 9 more outperform votes than Craneware when rated by MarketBeat users. Likewise, 75.38% of users gave EMIS Group an outperform vote while only 72.02% of users gave Craneware an outperform vote.
Craneware has a consensus target price of GBX 2,800, suggesting a potential upside of 32.70%. Given Craneware's stronger consensus rating and higher probable upside, analysts plainly believe Craneware is more favorable than EMIS Group.
In the previous week, EMIS Group and EMIS Group both had 3 articles in the media. Craneware's average media sentiment score of 0.18 beat EMIS Group's score of 0.00 indicating that Craneware is being referred to more favorably in the news media.
EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 6.18%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.
EMIS Group pays an annual dividend of GBX 42 per share. Craneware pays an annual dividend of GBX 29 per share and has a dividend yield of 1.4%. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware pays out 107.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware is clearly the better dividend stock, given its higher yield and lower payout ratio.
EMIS Group has a beta of -0.13, meaning that its share price is 113% less volatile than the S&P 500. Comparatively, Craneware has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500.
105.6% of EMIS Group shares are owned by institutional investors. Comparatively, 60.2% of Craneware shares are owned by institutional investors. 3.6% of EMIS Group shares are owned by company insiders. Comparatively, 19.3% of Craneware shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
EMIS Group has higher earnings, but lower revenue than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.
Summary
Craneware beats EMIS Group on 10 of the 18 factors compared between the two stocks.
Get Craneware News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Craneware Competitors List
Related Companies and Tools
This page (LON:CRW) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy CRW Stock Free CRW Stock Alerts